Skip to content
synth immune logo white
  • Concept
  • Projects
  • Technology Platforms
  • Who we are
  • Media & Press
  • Publications
  • Join us
  • Contact
SynthImmune - Cluster of Excellence - Logo
  • Concept
  • Projects
  • Technology Platforms
  • Who we are
  • Media & Press
  • Publications
  • Join us
  • Contact
SynthImmune - Cluster of Excellence - Logo
Home Spotlight Project Synthetic Immunology News

News

AllNewsOpen Positions
  • 13. July 2026
  • InEvents, News

Kick-off of the SynthImmune Seminar Series on September 17th

We are happy to announce our new SynthImmune Seminar Series! On every third Thursday of the month, we will invite external speakers to the large…

Read MoreKick-off of the SynthImmune Seminar Series on September 17th
Photograph of a open notepad in a lecture hall with people in the background
  • 7. July 2026
  • InUpcoming Talks

Upcoming Talk – Organized Beings and Living Beings: Reconceptualizing Kant’s Philosophy of Biology

Paula Órdens (University of Trier, Heidelberg University) will give a talk on July 7th at 3:30 pm CEST on Organized Beings and Living Beings: Reconceptualizing…

Read MoreUpcoming Talk – Organized Beings and Living Beings: Reconceptualizing Kant’s Philosophy of Biology
The lab of SynthImmune PI Chong Sun has published a paper in the journal Immunity entitled “Extracellular ATP-P2RY2 signaling drives intratumoral prostaglandin E2 accumulation and adaptive resistance to immunotherapy in solid tumors”.
  • 2. July 2026
  • InPublications, News

New publication in Immunity by SynthImmune PI Chong Sun

The lab of SynthImmune PI Chong Sun has published a paper in the journal Immunity entitled “Extracellular ATP-P2RY2 signaling drives intratumoral prostaglandin E2 accumulation and…

Read MoreNew publication in Immunity by SynthImmune PI Chong Sun
The labs of SynthImmune PIs Lukas Bunse, Katharina Lindner, and Michael Platten have published a paper in the journal Nature Cancer entitled “IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial".
  • 1. July 2026
  • InPublications, News

New publication in Nature Cancer by SynthImmune PIs Lukas Bunse, Katharina Lindner, and Michael Platten

The labs of SynthImmune PIs Lukas Bunse, Katharina Lindner, and Michael Platten have published a paper in the journal Nature Cancer entitled “IDH1-mutant vaccine in…

Read MoreNew publication in Nature Cancer by SynthImmune PIs Lukas Bunse, Katharina Lindner, and Michael Platten
The lab of SynthImmune PI Franziska Thomas has published a review in the journal Angewandte Chemie (International Edition) entitled “Late-Stage Functionalization of Peptides on the Solid Phase”.
  • 10. June 2026
  • InPublications, News

New publication in Angewandte Chemie by SynthImmune PI Franziska Thomas

The lab of SynthImmune PI Franziska Thomas has published a review in the journal Angewandte Chemie (International Edition) entitled “Late-Stage Functionalization of Peptides on the…

Read MoreNew publication in Angewandte Chemie by SynthImmune PI Franziska Thomas
Several SynthImmune PIs published a paper in the journal Nature Communications
  • 5. June 2026
  • InPublications, News

New publication in Nature Communications by several SynthImmune PIs

The labs of SynthImmune PIs Alessia Ruggieri, Joachim Spatz, Ilia Platzman, Oliver Fackler, and Kevin Jahnke have published a paper in the journal Nature Communications…

Read MoreNew publication in Nature Communications by several SynthImmune PIs
SynthImmune PI Lukas Bunse at the “Cellular Therapies for Malignant Brain Tumors” conference in Thailand
  • 27. May 2026
  • InEvents, News

SynthImmune PI Lukas Bunse at the “Cellular Therapies for Malignant Brain Tumors” conference in Thailand

SynthImmune PI Lukas Bunse recently attended the “Cellular Therapies for Malignant Brain Tumors” conference of Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy in Thailand,…

Read MoreSynthImmune PI Lukas Bunse at the “Cellular Therapies for Malignant Brain Tumors” conference in Thailand
  • 27. May 2026
  • InNews, Publications

New review article from the labs of Michael Platten and Chong Sun

The labs of SynthImmune PIs Michael Platten and Chong Sun have published a paper in the journal Nature Reviews Cancer entitled “Regulation of immune checkpoint…

Read MoreNew review article from the labs of Michael Platten and Chong Sun
SynthImmune PIs Frauke Mücksch and Oliver Fackler discuss the recent paper from MIT’s Mark Bathe’s lab on DNA origami vaccines in a research highlight in the journal Signal Transduction and Targeted Therapy.
  • 22. May 2026
  • InPublications, News

Research Highlight: DNA origami-based virus-like particles are new HIV vaccine candidates

SynthImmune PIs Frauke Mücksch and Oliver Fackler discuss the recent paper from MIT’s Mark Bathe’s lab on DNA origami vaccines in a research highlight in…

Read MoreResearch Highlight: DNA origami-based virus-like particles are new HIV vaccine candidates
The labs of SynthImmune PIs Oliver Fackler and Petr Chlanda have published a paper in the journal Nature Communications
  • 9. May 2026
  • InPublications, News

A new paper from the labs of Oliver Fackler and Petr Chlanda

The labs of SynthImmune PIs Oliver Fackler and Petr Chlanda have published a paper in the journal Nature Communications entitled “A tissue-intrinsic mechanism sensitizes HIV-1…

Read MoreA new paper from the labs of Oliver Fackler and Petr Chlanda
synth immune logo white
Department of Infectious Diseases Integrative Virology
University Hospital Heidelberg
Im Neuenheimer Feld 344
  • Phone: +49 6221 56-5061
  • Email: SynthImmune@med.uni-heidelberg.de
  • Home
  • Contact
  • Privacy Statement
  • Imprint
Copyright © 2025 - agentur-rubbeldiekatz.de